Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom 
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity 
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability 
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids 
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites 
Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure 
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling 
xAI Cash Burn Highlights the High Cost of Competing in Generative AI 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
Nvidia Appoints Former Google Executive Alison Wagonfeld as First Chief Marketing Officer 
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid 
Rio Tinto–Glencore Merger Talks Spark Investor Debate Over Value, Strategy and Coal Exposure 
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks 
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges 
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S. 
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move 
EU Orders Elon Musk’s X to Preserve Grok AI Data Amid Probe Into Illegal Content 
EDEN PRAIRIE, Minn., Oct. 25, 2017 -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today that its third quarter 2017 results will be released on Tuesday, October 31, 2017, before the open of the stock market. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management will discuss the company’s financial results and provide a general business overview.
To access the live webcast, please visit the Investors page of the CHF Solutions website at www.chf-solutions.com. Alternatively, you may access the live conference call by dialing (877) 303-9826 (U.S.) or (224) 357-2194 (international) and using conference ID 2559289. An audio archive of the webcast and the call script will be available following the call on the Investor page at www.chf-solutions.com.
About CHF Solutions
CHF Solutions, Inc. (NASDAQ:CHFS) is a medical device company focused on commercializing the Aquadex FlexFlow system for Aquapheresis® therapy. The Aquadex FlexFlow system, is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. All treatments must be administered by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies. The company's objective is to improve the quality of life for patients with heart failure and related conditions. CHF Solutions is a Delaware corporation headquartered in Minneapolis with wholly owned subsidiaries in Australia and Ireland. The company has been listed on the NASDAQ Capital Market since February 2012.
For further information, please contact:
Claudia Napal Drayton Investor Relations
Chief Financial Officer CHF Solutions, Inc.
CHF Solutions, Inc. [email protected]
T: +1-952-345-4205
-or-
Bret Shapiro
Managing Partner
CORE IR
516 222 2560
[email protected]
www.coreir.com
